Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
December 08, 2022 16:00 ET
|
Zealand Pharma
Company announcement – No. 57 / 2022 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark and Boston, MA, U.S. December 8, 2022 –...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
December 02, 2022 12:05 ET
|
Zealand Pharma
Company announcement – No. 56/ 2022 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Zealand Pharma grants sign-on warrants and performance stock units under the employee warrant program and management long-term incentive program
December 02, 2022 12:00 ET
|
Zealand Pharma
Company announcement – No. 55/ 2022 Zealand Pharma grants sign-on warrants and performance stock units under the employee warrant program and management long-term incentive program ...
Total number of shares and voting rights in Zealand Pharma at November 30, 2022
November 30, 2022 11:05 ET
|
Zealand Pharma
Company announcement – No. 54 / 2022 Total number of shares and voting rights in Zealand Pharma at November 30, 2022 Copenhagen, Denmark and Boston, MA, U.S. November 30, 2022 – Zealand Pharma A/S...
Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants
November 17, 2022 15:55 ET
|
Zealand Pharma
Company announcement – No. 53 / 2022 Zealand Pharma Increases its Share Capital as a Consequence of Exercise of Employee Warrants Copenhagen, Denmark and Boston, MA, U.S. November 17,...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
November 17, 2022 11:29 ET
|
Zealand Pharma
Company announcement – No. 52 / 2022 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Zealand Pharma Announces Financial Results for the First Nine Months of 2022
November 10, 2022 09:00 ET
|
Zealand Pharma
Company announcement No. 51 / 2022 Zealand Pharma Announces Financial Results for the First Nine Months of 2022 Copenhagen, Denmark November 10, 2022 – Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no....
Zealand Pharma to Participate in Upcoming Investor Conferences
November 08, 2022 08:30 ET
|
Zealand Pharma
Company announcement – No. 50 / 2022 Zealand Pharma to Participate in Upcoming Investor Conferences Copenhagen, Denmark and Boston, MA, U.S. November 8, 2022 – a Zealand Pharma A/S (CVR-no....
Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022
November 03, 2022 04:00 ET
|
Zealand Pharma
Company announcement – No. 49 / 2022 Zealand Pharma Hosts Conference Call on November 10 at 4pm CET (10am ET) to Present Third Quarter Results for 2022 Copenhagen, Denmark and Boston, MA,...
Zealand Pharma Announces Presentations at The Obesity Society Annual Meeting
November 01, 2022 12:00 ET
|
Zealand Pharma
Press release – No. 7 / 2022 Zealand Pharma Announces Presentations at The Obesity Society Annual Meeting Results from the phase 2 clinical trial of GCGR/GLP-1R dual agonist BI 456906 showing...